Fufeng Group Limited

DB:FFO1 Stock Report

Market Cap: €1.4b

Fufeng Group Valuation

Is FFO1 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of FFO1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: FFO1 (€0.55) is trading below our estimate of fair value (€0.91)

Significantly Below Fair Value: FFO1 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for FFO1?

Key metric: As FFO1 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for FFO1. This is calculated by dividing FFO1's market cap by their current earnings.
What is FFO1's PE Ratio?
PE Ratio4x
EarningsCN¥2.65b
Market CapCN¥10.63b

Price to Earnings Ratio vs Peers

How does FFO1's PE Ratio compare to its peers?

The above table shows the PE ratio for FFO1 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average48.7x
BAS BASF
76x34.2%€38.4b
SDF K+S
78.8x61.1%€2.0b
ACT AlzChem Group
11.9x12.6%€594.3m
WCH Wacker Chemie
28.3x37.0%€3.6b
FFO1 Fufeng Group
4x8.8%€11.4b

Price-To-Earnings vs Peers: FFO1 is good value based on its Price-To-Earnings Ratio (4x) compared to the peer average (49.3x).

Price to Earnings Ratio vs Industry

How does FFO1's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
FFO1 4.0xIndustry Avg. 17.1xNo. of Companies13PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: FFO1 is good value based on its Price-To-Earnings Ratio (4x) compared to the European Chemicals industry average (17.1x).

Price to Earnings Ratio vs Fair Ratio

What is FFO1's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

FFO1 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio4x
Fair PE Ratio15.1x

Price-To-Earnings vs Fair Ratio: FFO1 is good value based on its Price-To-Earnings Ratio (4x) compared to the estimated Fair Price-To-Earnings Ratio (15.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst FFO1 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€0.55
€0.68
+24.2%
10.4%€0.75€0.61n/a2
Nov ’25€0.52
€0.68
+32.6%
10.4%€0.75€0.61n/a2
Oct ’25€0.55
€0.68
+24.2%
10.4%€0.75€0.61n/a2
Sep ’25€0.50
€0.69
+38.2%
10.9%€0.77€0.62n/a2
Aug ’25€0.53
€0.73
+38.0%
5.8%€0.77€0.69n/a2
Jul ’25€0.61
€0.73
+18.9%
5.8%€0.77€0.69n/a2
Jun ’25€0.71
€0.73
+2.3%
5.8%€0.77€0.69n/a2
Apr ’25€0.57
€0.73
+28.0%
5.9%€0.77€0.69n/a2
Mar ’25€0.55
€0.72
+31.5%
5.8%€0.77€0.68n/a2
Feb ’25€0.50
€0.72
+45.8%
5.8%€0.77€0.68n/a2
Jan ’25€0.49
€0.72
+48.8%
5.8%€0.77€0.68n/a2
Dec ’24€0.48
€0.72
+49.5%
5.8%€0.77€0.68n/a2
Nov ’24€0.48
€0.72
+50.1%
5.8%€0.77€0.68€0.522
Oct ’24€0.53
€0.72
+37.8%
5.8%€0.77€0.68€0.552
Sep ’24€0.47
€0.72
+53.9%
5.8%€0.77€0.68€0.502
Aug ’24€0.47
€0.80
+70.4%
16.9%€0.94€0.67€0.532
Jul ’24€0.44
€0.80
+80.4%
16.9%€0.94€0.67€0.612
Jun ’24€0.52
€0.80
+55.5%
16.9%€0.94€0.67€0.712
May ’24€0.54
€0.80
+49.7%
16.9%€0.94€0.67€0.702
Mar ’24€0.61
€0.87
+42.4%
14.5%€0.99€0.74€0.552
Feb ’24€0.64
€0.87
+36.8%
14.5%€0.99€0.74€0.502
Jan ’24€0.56
€0.87
+53.7%
14.5%€0.99€0.74€0.492
Dec ’23€0.63
€0.87
+37.9%
14.5%€0.99€0.74€0.482
Nov ’23€0.52
€0.87
+67.0%
14.5%€0.99€0.74€0.482

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

Stanmore Resources

AU$2.8b

Engages in the exploration, development, production, and sale of metallurgical coal in Australia.

S0D

AU$1.88

7D

0.5%

1Y

-16.8%

Tokuyama

JP¥197.6b

Produces and sells various chemical products in Japan.

TBT

JP¥16.70

7D

5.0%

1Y

16.0%

Mitsubishi Chemical Group

JP¥1.2t

Provides performance products, chemicals, industrial gases, health care products, and other products in Japan and internationally.

M3C

JP¥5.27

7D

2.9%

1Y

-8.1%